Lovin’ Lumos!
In immediately’s episode of Trading Up, Colin explains why shares of biotech inventory Lumos Diagnostic surged 563 per cent on the again of FDA approval.
Plus, Bill Beament’s Develop Global lobs bid for lithium junior Essential Metals and the most important IPO of the yr Redox slips into the pink.
WATCH THE LATEST EPISODE IN THE VIDEO PLAYER ABOVE
Source: www.perthnow.com.au
